|
⚲
|
| Keyboard |
| Glover Stephen C
✚
|
|
|---|---|
| CIK # | 0001304406 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001304406] | |
| 4 | [0001304406] | |
| SC 13D | [0001304406] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Glover Stephen C | Zyversa Therapeutics Inc | [2022-12-22] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Oncolytics Biotech Inc | |
| Glover Steve C | |
| PDS Biotechnology Corp | |
| ZyVersa Therapeutics Inc | |
| Ambrx Biopharma Inc | |
| Ambrx Biopharma Cayman Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PDS Biotechnology Corp PDSB
Employee Stock Option (Right to Buy) · derivative
|
2026-01-12 | Grant | 54,876 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options · derivative
|
2025-07-11 | Grant | 136,900 | $0.00 | |
|
PDS Biotechnology Corp PDSB
Employee Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 22,700 | $0.00 | |
|
PDS Biotechnology Corp PDSB
Common Warrant · derivative
|
2025-02-28 | Buy | 15,061 | ||
|
PDS Biotechnology Corp PDSB
Common Stock
|
2025-02-28 | Buy | 15,061 | $1.66 | 25,001 |
|
PDS Biotechnology Corp PDSB
Employee Stock Option (Right to Buy) · derivative
|
2024-06-24 | Grant | 9,000 | $0.00 | |
|
Ambrx Biopharma Inc AMAM
Option to Purchase Common Stock · derivative
|
2024-03-07 | Disposed to issuer | 2,500 | ||
|
Ambrx Biopharma Inc AMAM
Option to Purchase Common Stock · derivative
|
2024-03-07 | Disposed to issuer | 30,000 | ||
|
Ambrx Biopharma Inc AMAM
Restricted Stock Units · derivative
|
2024-03-07 | Disposed to issuer | 12,142 | ||
|
Ambrx Biopharma Inc AMAM
Option to Purchase Common Stock · derivative
|
2024-03-07 | Disposed to issuer | 5,714 | ||
|
PDS Biotechnology Corp PDSB
Employee Stock Option (Right to Buy) · derivative
|
2023-07-14 | Grant | 9,000 | $0.00 | |
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-06-07 | Grant | 40,000 | $0.00 | |
|
Ambrx Biopharma Cayman Inc AMAM
Ordinary Shares
|
2023-06-07 | Grant | 85,000 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options · derivative
|
2023-05-24 | Grant | 1,627 | $0.00 | |
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-05-18 | Grant | 210,000 | $0.00 | |
|
Ambrx Biopharma Cayman Inc AMAM
Stock Option (right to buy) · derivative
|
2023-05-18 | Grant | 17,500 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Stock Options (right to buy) · derivative
|
2022-12-12 | Grant | 138,980 | $0.00 | |
|
ZyVersa Therapeutics Inc ZVSA
Common Stock
|
2022-12-12 | Grant | 49,636 | ||
|
ZyVersa Therapeutics Inc ZVSA
Common Stock
|
2022-12-12 | Grant | 85,442 | ||
|
ZyVersa Therapeutics Inc ZVSA
Common Stock
|
2022-12-12 | Grant | 448,909 | ||
| showing 20 of 36 most recent transactions | |||||